GLP-1 Dosing Schedules Explained
Why GLP-1 doses start low and step up slowly, what the typical semaglutide and tirzepatide schedules look like, and how to handle a rough week.
8 min read · Last reviewed 2026-10-05 by the Top GLP-1 Editorial Team
Educational, not medical advice. This page explains GLP-1 medications in general terms. Only a licensed clinician who knows your history can decide what's right for you.
Key takeaways
- Every GLP-1 — injection or pill — starts low and increases about every 4 weeks to limit nausea.
- The starter dose isn't meant to cause much weight loss — it's for tolerance.
- You don't always need the maximum dose to get results.
- Slowing down escalation is a normal, safe response to side effects.
- The new oral GLP-1 pills titrate on the same slow-ramp principle: oral Wegovy climbs to 25 mg, orforglipron to 17.2 mg.
- For a missed dose, follow the product-specific window — and never double up to catch up.
Why the slow ramp-up
Every GLP-1 medication is dose-escalated: you start at a low dose and increase it in steps, usually every four weeks. This isn't bureaucracy — it's the single most important thing that determines whether your first two months are tolerable.
Starting at a full dose overwhelms the gut and causes severe nausea and vomiting. The gradual schedule lets your digestive system adapt to slower emptying before the appetite effect is turned up.
The typical semaglutide (Wegovy) schedule
- Weeks 1–4: 0.25 mg weekly (starter — tolerance, not weight loss)
- Weeks 5–8: 0.5 mg weekly
- Weeks 9–12: 1.0 mg weekly
- Weeks 13–16: 1.7 mg weekly
- Week 17 onward: 2.4 mg weekly (maintenance)
The typical tirzepatide (Zepbound) schedule
- Weeks 1–4: 2.5 mg weekly (starter)
- Weeks 5–8: 5 mg weekly (first therapeutic dose)
- Weeks 9–12: 7.5 mg weekly
- Weeks 13–16: 10 mg weekly
- Then, if needed: 12.5 mg → 15 mg weekly
Oral GLP-1 dosing: the new pills
GLP-1s now come as pills too, and they titrate on exactly the same slow-ramp principle — start low, step up roughly every 30 days to a maintenance dose. There are two FDA-approved weight-loss pills in 2026, and how you take them differs in one important way.
Oral Wegovy (oral semaglutide) must be taken on an empty stomach first thing in the morning, with no more than about 4 ounces of plain water, then a 30-minute wait before eating, drinking or taking anything else — getting that routine right is what makes the dose actually work. Orforglipron (Foundayo) has no such restriction: as a small molecule it can be taken at any time, with or without food or water.
- Oral Wegovy (oral semaglutide): climbs roughly monthly from 1.5 mg → 4 mg → 9 mg → 25 mg daily (maintenance), taken on an empty stomach with the 30-minute rule.
- Orforglipron (Foundayo): 0.8 mg → 2.5 mg → 5.5 mg, then if needed 9 → 14.5 → 17.2 mg daily (max), at least 30 days per step — any time of day, with or without food or water.
- As with the injections, the top strength is a ceiling, not a target — many people hold at a middle dose.
You may not need the top dose
The maximum dose is a ceiling, not a target. Plenty of people reach their goal weight and feel great at an intermediate dose — 1.0 mg semaglutide or 5–10 mg tirzepatide — and never go higher. The right dose is the lowest one that keeps you progressing with manageable side effects.
What if I miss a dose?
The rule depends on whether your medication is weekly or daily, and the exact window is set by the product instructions — but the principle is universal: never double up to "catch up," which stacks side effects.
- Weekly injectable semaglutide (Wegovy): if your next scheduled dose is at least 2 days (48 hours) away, take the missed dose as soon as you can; if it's sooner than that, skip it and resume your normal schedule.
- Weekly injectable tirzepatide (Zepbound): a missed dose can generally be taken within about 4 days (96 hours); after that, skip it and take the next dose on schedule.
- Daily pills (oral Wegovy, orforglipron): skip a missed day and take the next day's dose as normal — don't take two in one day.
- Orforglipron specifically: if you miss about a week or more of consecutive doses, your prescriber may have you restart the dose escalation at a lower step.
- When in doubt, follow the instructions that came with your medication or ask your prescriber.
When a week is rough
If a dose increase brings side effects you can't live with, the standard move is to hold at your current dose for another few weeks rather than push up, or to step back down. This is normal and safe, and a good clinician expects it. What you should not do is double up after a missed dose or accelerate the schedule to “catch up.”
Compounded products can differ in concentration between pharmacies, so dose by the milligrams your prescriber specifies, not by lines on the syringe.
Sources & references
Clinical figures on this page trace to peer-reviewed trials and official regulators. We link the primary record so you can verify it yourself.
- 1.Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989–1002.Clinical trialNew England Journal of Medicine
- 2.Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205–216.Clinical trialNew England Journal of Medicine
- 3.U.S. Food & Drug Administration / Eli Lilly. FOUNDAYO (orforglipron) tablets — Prescribing Information. Initial U.S. Approval: 2026.RegulatoryU.S. Food & Drug Administration (DailyMed)
- 4.
Further reading
- GLP-1 weight-loss pills: orforglipron & oral Wegovy — the full guide
Our in-depth guide to the two FDA-approved GLP-1 pills: how well they work, side effects, full dosing, cost, and how they compare to the injections.